Table 5.
Age | ASA-PS / Relevant medical history | Surgery | Anesthetic technique/Number of attempts | EC length of stay (days) | Symptoms (days after EC placement) | EC tip – Microbiologic study | Treatment | |
---|---|---|---|---|---|---|---|---|
Epidural abscess | 39 | II /Inflammatory Bowel Disease | Major digestive | Lumbar Epidural / 3 | 3 | Spinal pain and fever (D4), sensory deficit (D12) | MRSA | Antibiotic and neurosurgical decompression |
65 | IV / Heart Transplant; DM | Major orthopedic | Lumbar CSE / 4 | 13 | Spinal pain (D13), sensory and motor deficits (D33) | MRSA | ||
61 | II / Prostate cancer; DMa | Peripheral vascular | Lumbar CSE/ 3 | 6 | Spinal pain and fever (D11) | Negative | ||
Subcutaneous cell tissue hematoma | 62 | III / DM; HF | Major orthopedic | Lumbar CSE/1 | 16 | Spinal pain and inflammatory signs (D11) | Negative | Antibiotic |
70 | III / CRD; HF | Major orthopedic | Lumbar CSE/ 1 | 5 | Spinal pain and inflammatory signs (D14) | MRSA | Antibiotic | |
62 | III/ Epilepsy; Malignant disease | Major digestive | Lumbar Epidural / 2 | 4 | Sensory and motor deficits (D4) | Not applicable | Surveillance | |
Arachnoiditis | 69 | III / Obesity | Peripheral vascular | Lumbar CSE / 3 | 5 | Spinal pain and sensory deficits (D13) | Negative | Antibiotic |
ASA-PS, American Society of Anesthesiologists Physical Status; CRD, chronic renal disease; CSE, combined spinal epidural; DM, diabetes mellitus; EC, epidural catheter; HF, heart failure; MRSA, methicillin-resistant staphylococcus aureus.
Patient with Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia sepsis.